MUMBAI, India and NAPLES, Fla. 鈥� Global pharmaceutical leader Lupin Limited today announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States following the approval for its Abbreviated New 91短视频 Application from the U.S. FDA as bioequivalent to Farxiga庐 for the indications in the approved labeling.
To know more, visit or follow us on LinkedIn
Farxiga is a registered trademark of AstraZeneca AB.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
